Dr. Santosh Kesari Has Been Recognized Among the Top in His Industry by the Expert Network©

Santa Monica, CA, May 23, 2017 (Newswire.com) - Dr. Santosh Kesari, Chair, Department of Translational Neurosciences & Neurotherapeutics, John Wayne Cancer Institute & Pacific Neuroscience Institute, has joined The Expert Network©, an invitation-only service for distinguished professionals. Dr. Kesari has been chosen as a Distinguished Doctor™ based on peer reviews and ratings, numerous recognitions, and accomplishments achieved throughout his career.

Dr. Kesari outshines others in his field due to his extensive educational background, career longevity, and numerous awards and recognitions. He emigrated to the United States as a boy and never lost sight of his childhood ambition. After graduating from the University of Pennsylvania with a Bachelor’s degree in Biology and Mathematics, he remained at the Ivy League school, where he went on to earn his medical degree. He completed his residency in Neurology at the Harvard’s Brigham & Women's Hospital, where he then became a Clinical Fellow under the mentorship of Drs. Patrick Y. Wen and Tracey T. Batchelor. Dr. Kesari also holds a Ph.D. from the University of Pennsylvania in Molecular Biology and is a Fellow of the American Academy of Neurology (FAAN) as well as the American Neurological Association (FANA).

"There is a high unmet need for brain cancers, and our goal in the next 5 years is to contribute to the development of new drugs and to the approval of a new treatment approach for brain cancers."

Santosh Kesari, M.D., Ph.D., Chair, Department of Translational Neurosciences & Neurotherapeutics, John Wayne Cancer & Pacific Neuroscience Institutes

With more than 17 years dedicated to medicine, Dr. Kesari brings a wealth of knowledge to his industry and, in particular, to his area of expertise, neurology and neuro-oncology. When asked why he decided to pursue a career in medicine, Dr. Kesari said:

"My father was a physician, he was a family doctor and was the primary motivation for my interest in pursuing a career in medicine."

Since completing his training, Dr. Kesari has committed his career to helping patients with brain cancer through his practice and his research. Dr. Kesari began his career in Boston, where he was both an Attending Physician at the Brigham & Women's Hospital as well as the Dana-Farber Cancer Institute, and taught as an Assistant Professor of Neurology at Harvard Medical School. In 2009, he moved to Southern California and began practicing with the UC San Diego Medical Center and Providence Saint John’s Health Center. He also served as a Professor of Neurosciences at UC San Diego until 2015.

Throughout his career, Dr. Kesari’s research efforts have focused on cancer stem cells, their role in the formation of brain tumors and their resistance to treatment. His primary goal remains the advancement of neurological medicine by developing targeted drugs to eradicate brain tumors. As a researcher, he has more than 300 publications, including original articles, reviews, editorials, books, and clinical communications. He also has patented dozens of innovative treatments and he works closely with prominent companies in the pharmaceutical and biotechnology industries to bring those patents to reality. Additionally, Dr. Kesari sits on the Editorial Board or is an Ad-hoc Reviewer for numerous prominent medical journals in his specialty, including the Nature Scientific Reports and Journal of Translational Medicine.

Recognized as one of America’s Top Doctors by Castle Connolly, U.S. News & World Report, and other publications, Dr. Kesari puts his expert knowledge to good use as a compassionate physician. Dedicated first and foremost to the well-being of his patients, he provides personalized care to those with malignant brain tumors through precise therapeutic strategies that target brain tumors at the molecular level to eliminate the disease.

As a thought-leader in his specialty, Dr. Kesari remains at the forefront of prevailing trends in neuro-oncology. He noted:

"There is a high unmet need for brain cancers, and our goal in the next 5 years is to contribute to the development of new drugs and to the approval of a new treatment approach for brain cancers."

For more information, visit Dr. Kesari's profile on the Expert Network here: https://expertnetwork.co/members/santosh-kesari,-md,-phd/0f99c71e015cba3f

The Expert Network© has written this news release with approval and/or contributions from Dr. Santosh Kesari. The Expert Network© is an invitation-only reputation management service that is dedicated to helping professionals stand out, network, and gain a competitive edge. The Expert Network selects a limited number of professionals based on their individual recognitions and history of personal excellence.

Source: The Expert Network©